Patents by Inventor Garry M. Steil

Garry M. Steil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8348923
    Abstract: An infusion system, which may be a closed loop, or “semi-closed-loop”, infusion system, uses state variable feedback to control the rate at which fluid is infused into a user's body. The closed loop system includes a sensor system, a controller, and a delivery system. The “semi-closed-loop” system further includes prompts that provide indications to the user prior to fluid delivery. The sensor system includes a sensor for monitoring a condition of the user and produces a sensor signal which is representative of the user's condition. The delivery system infuses a fluid into the user at a rate dictated by the commands from the controller. The system may use three state variables, e.g., subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and corresponding gains, to calculate an additional amount of fluid to be infused with a bolus and to be removed from the basal delivery of the fluid.
    Type: Grant
    Filed: August 12, 2010
    Date of Patent: January 8, 2013
    Assignee: Medtronic Minimed, Inc.
    Inventors: Sami S. Kanderian, Jr., Garry M. Steil
  • Patent number: 8348886
    Abstract: An infusion system, which may be a closed loop infusion system or “semi-closed-loop” system, uses state variable feedback to control the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The “semi-closed-loop” system further includes prompts that are displayed or sounded or otherwise provide indications to the user prior to fluid delivery. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The delivery system infuses a fluid into the user at a rate dictated by the commands from the controller. The system may use three state variables, subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and corresponding gains, to calculate an additional amount of fluid to be infused as a bolus and to be removed from the basal delivery of the fluid.
    Type: Grant
    Filed: May 1, 2009
    Date of Patent: January 8, 2013
    Assignee: Medtronic Minimed, Inc.
    Inventors: Sami S. Kanderian, Jr., Garry M. Steil
  • Publication number: 20120259278
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Application
    Filed: June 21, 2012
    Publication date: October 11, 2012
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, JR., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
  • Patent number: 8226556
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Grant
    Filed: May 6, 2009
    Date of Patent: July 24, 2012
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
  • Publication number: 20110282321
    Abstract: A system and method for controlling and monitoring a diabetes-management system through the use of a model that predicts or estimates future dynamic states of glucose and insulin from variables such as insulin delivery or exogenous glucose appearance as well as inherent physiological parameters. The model predictive estimator can be used as an insulin bolus advisor to give an apriori estimate of postprandial glucose for a given insulin delivery profile administered with a known meal to optimize insulin delivery; as a supervisor to monitor the operation of the diabetes-management system; and as a model predictive controller to optimize the automated delivery of insulin into a user's body to achieve a desired blood glucose profile or concentration. Open loop, closed-loop, and semi-closed loop embodiments of the invention utilize a mathematical metabolic model that includes a Minimal Model, a Pump Delivery to Plasma Insulin Model, and a Meal Appearance Rate Model.
    Type: Application
    Filed: June 27, 2011
    Publication date: November 17, 2011
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: GARRY M. STEIL, Sami S. Kanderian, JR., Martin T. Cantwell, Udo Hoss
  • Publication number: 20110282320
    Abstract: A system and method for controlling and monitoring a diabetes-management system through the use of a model that predicts or estimates future dynamic states of glucose and insulin from variables such as insulin delivery or exogenous glucose appearance as well as inherent physiological parameters. The model predictive estimator can be used as an insulin bolus advisor to give an apriori estimate of postprandial glucose for a given insulin delivery profile administered with a known meal to optimize insulin delivery; as a supervisor to monitor the operation of the diabetes-management system; and as a model predictive controller to optimize the automated delivery of insulin into a user's body to achieve a desired blood glucose profile or concentration. Open loop, closed-loop, and semi-closed loop embodiments of the invention utilize a mathematical metabolic model that includes a Minimal Model, a Pump Delivery to Plasma Insulin Model, and a Meal Appearance Rate Model.
    Type: Application
    Filed: June 27, 2011
    Publication date: November 17, 2011
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: GARRY M. STEIL, Sami S. Kanderian, JR., Martin T. Cantwell, Udo Hoss
  • Publication number: 20100324382
    Abstract: Disclosed are a method and/or system for determining a suggested change in a recommended therapy for a patient based, at least in part, on sensor measurements, and generating an alert to an attendant in a hospital environment upon detection of the suggested change. In another embodiment, a method and/or system is directed to automatically determining a maximum interval to alert an attendant following receipt of a measurement at an operator interface. In yet another embodiment, a method and/or system is directed to blood-glucose sensor calibration.
    Type: Application
    Filed: June 17, 2009
    Publication date: December 23, 2010
    Applicant: Medtronic Minimed, Inc.
    Inventors: Martin Cantwell, H. Bud Clark, Garry M. Steil
  • Publication number: 20100305545
    Abstract: An infusion system, which may be a closed loop, or “semi-closed-loop”, infusion system, uses state variable feedback to control the rate at which fluid is infused into a user's body. The closed loop system includes a sensor system, a controller, and a delivery system. The “semi-closed-loop” system further includes prompts that provide indications to the user prior to fluid delivery. The sensor system includes a sensor for monitoring a condition of the user and produces a sensor signal which is representative of the user's condition. The delivery system infuses a fluid into the user at a rate dictated by the commands from the controller. The system may use three state variables, e.g., subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and corresponding gains, to calculate an additional amount of fluid to be infused with a bolus and to be removed from the basal delivery of the fluid.
    Type: Application
    Filed: August 12, 2010
    Publication date: December 2, 2010
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: SAMI S. KANDERIAN, JR., GARRY M. STEIL
  • Patent number: 7806886
    Abstract: An infusion system, which may be a closed loop, or “semi-closed-loop”, infusion system, uses state variable feedback to control the rate at which fluid is infused into a user's body. The closed loop system includes a sensor system, a controller, and a delivery system. The “semi-closed-loop” system further includes prompts that provide indications to the user prior to fluid delivery. The sensor system includes a sensor for monitoring a condition of the user and produces a sensor signal which is representative of the user's condition. The delivery system infuses a fluid into the user at a rate dictated by the commands from the controller. The system may use three state variables, e.g., subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and corresponding gains, to calculate an additional amount of fluid to be infused with a bolus and to be removed from the basal delivery of the fluid.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: October 5, 2010
    Assignee: Medtronic Minimed, Inc.
    Inventors: Sami S. Kanderian, Jr., Garry M. Steil
  • Patent number: 7766830
    Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.
    Type: Grant
    Filed: November 30, 2004
    Date of Patent: August 3, 2010
    Assignee: Medtronic MiniMed, Inc.
    Inventors: James Kelly Fox, Garry M. Steil, Kerstin Rebrin, Mark C. Estes, Frank Saidara
  • Publication number: 20100114015
    Abstract: An infusion system, which may be a closed loop infusion system or “semi-closed-loop” system, uses state variable feedback to control the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The “semi-closed-loop” system further includes prompts that are displayed or sounded or otherwise provide indications to the user prior to fluid delivery. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The delivery system infuses a fluid into the user at a rate dictated by the commands from the controller. The system may use three state variables, subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and corresponding gains, to calculate an additional amount of fluid to be infused as a bolus and to be removed from the basal delivery of the fluid.
    Type: Application
    Filed: May 1, 2009
    Publication date: May 6, 2010
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Sami S. Kanderian, JR., Garry M. Steil
  • Publication number: 20090234213
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Application
    Filed: May 6, 2009
    Publication date: September 17, 2009
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, JR., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
  • Patent number: 7547281
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Grant
    Filed: December 30, 2005
    Date of Patent: June 16, 2009
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
  • Publication number: 20090062767
    Abstract: Embodiments of the invention provide a dual insertion set for supplying a fluid to the body of a patient and for monitoring a body characteristic of the patient. Typical embodiments of the invention include a base, an infusion portion coupled to a first piercing member and a sensor portion coupled to a second piercing member. The infusion portion includes a cannula coupled to the piercing member for supplying a fluid to a placement site. The sensor portion includes a sensor coupled to and extending from the base having at least one sensor electrode formed on a substrate and is coupled to the piercing member in a manner that allows the sensor to be inserted at the placement site. The base is arranged to secure the dual insertion set to the skin of a patient.
    Type: Application
    Filed: August 29, 2007
    Publication date: March 5, 2009
    Inventors: Nannette M. Van Antwerp, Rajiv Shah, Bradley J. Enegren, Richard Lemos, JR., Ly Phou, Garry M. Steil, Gayane R. Voskanyan
  • Publication number: 20080188796
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Application
    Filed: April 4, 2008
    Publication date: August 7, 2008
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Garry M. Steil, Kerstin Rebrin
  • Publication number: 20080183060
    Abstract: A system and method for controlling and monitoring a diabetes-management system through the use of a model that predicts or estimates future dynamic states of glucose and insulin from variables such as insulin delivery or exogenous glucose appearance as well as inherent physiological parameters. The model predictive estimator can be used as an insulin bolus advisor to give an apriori estimate of postprandial glucose for a given insulin delivery profile administered with a known meal to optimize insulin delivery; as a supervisor to monitor the operation of the diabetes-management system; and as a model predictive controller to optimize the automated delivery of insulin into a user's body to achieve a desired blood glucose profile or concentration. Open loop, closed-loop, and semi-closed loop embodiments of the invention utilize a mathematical metabolic model that includes a Minimal Model, a Pump Delivery to Plasma Insulin Model, and a Meal Appearance Rate Model.
    Type: Application
    Filed: January 31, 2007
    Publication date: July 31, 2008
    Inventors: Garry M. Steil, Sami S. Kanderian, Martin T. Cantwell, Udo Hoss
  • Patent number: 7402153
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: July 22, 2008
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Garry M. Steil, Kerstin Rebrin
  • Publication number: 20080097289
    Abstract: An algorithm and method of making intelligent therapy recommendations for insulin pump parameters is described. The pump parameters include basal rates, carbohydrate-to-insulin ratios (CIR), and insulin sensitivity factors (ISF). A determination of whether a therapy recommendation should be made is based on comparing an updated recommended change with a threshold. The updated recommended change to the pump parameter is made based on a previous recommended change to the pump parameter and the difference between a current blood glucose value and a targeted blood glucose level. The algorithm and method confirms the therapy recommendation is within safety parameters before displaying the therapy recommendation.
    Type: Application
    Filed: September 6, 2006
    Publication date: April 24, 2008
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Garry M. Steil, Antonios Panteleon
  • Patent number: 7354420
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Grant
    Filed: May 3, 2006
    Date of Patent: April 8, 2008
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Garry M. Steil, Kerstin Rebrin
  • Patent number: 7267665
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Grant
    Filed: December 31, 2002
    Date of Patent: September 11, 2007
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Garry M. Steil, Kerstin Rebrin